Loads of analysts cut their price targets on these 10 stocks ahead of earnings
CNBC - 2024-04-17T23:31:28.000Z

CNBC Pro screened for global stocks that have had their upside potential cut over the past seven days and ahead of earnings.

In related news

Netflix Earnings Preview: Analysts Raise Stock Price Targets on Ad Tier, Paid Sharing Optimism
The ad tier is also a "pricing power booster," argues one expert, because it "gives Netflix the ability to further stretch the upper end of its pricing range, as it serves a 'safety net' to potential churners."
- Related Articles
- In News
- From The Hollywood Reporter
- 2024-04-15T20:37:30.000Z
Pivotree (CVE:PVT) Price Target Cut to C$3.50 by Analysts at Cormark
Pivotree (CVE:PVT – Free Report) had its price target lowered by Cormark from C$5.00 to C$3.50 in a report published on Monday, BayStreet.CA reports. Cormark also issued estimates for Pivotree’s FY2024 earnings at ($0.08) EPS and FY2025 earnings at ($0.04) EPS. A number of other research analysts also recently issued reports on the company. National […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-04-05T01:28:42.000Z
Pacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $3.00 by Analysts at Barclays
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its target price dropped by investment analysts at Barclays from $8.00 to $3.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the biotechnology company’s stock. Barclays‘s price objective suggests a potential downside of 10.18% from the […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-04-10T16:20:42.000Z